To confirm the interaction between endogenous BCL2 and IRF4 proteins, a co‐immunoprecipitation assay was performed using DLBCL cells expressing both BCL2 and IRF4. The gene discussed is IRF4; the disease is diffuse large B-cell lymphoma.